Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C
Open Access
- 6 March 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (20) , 32618-32625
Abstract
Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CKeywords
This publication has 19 references indexed in Scilit:
- Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of TreatmentClinical Cancer Research, 2017
- Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]EBioMedicine, 2017
- Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusHepatology, 2015
- MICA SNPs and the NKG2D system in virus-induced HCCJournal of Gastroenterology, 2014
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infectionJournal of Hepatology, 2014
- Genomics and HCV infection: Progression of fibrosis and treatment responseJournal of Hepatology, 2012
- Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular CarcinomaPLOS ONE, 2012
- Chronic hepatitis C infection in the elderlyThe Kaohsiung Journal of Medical Sciences, 2011
- Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detectionJournal of General Virology, 1993
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991